Home LiteratureArticle Details
PMID: 2991591 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells.

Journal of virology ·Vol. 55 ·No. 3 ·1985-09-00 ·Pages 710-20

Mann KP, Staunton D, Thorley-Lawson DA

Abstract

We have developed monoclonal antibodies to a 63,000-molecular-weight protein (p63) which is the product of the most abundant messenger RNA in Epstein-Barr virus-transformed cells and shown that the protein is associated specifically with plasma membranes. It was also found to be associated with the other membrane fractions and was found in all Epstein-Barr virus-transformed cells tested. In addition, p63 was present in virions, resulting in transient, early appearance in newly infected cells. Newly synthesized p63 was detected at the time cells underwent blast transformation (48 to 72 h postinfection). The possible role of this protein in transformation and as a target for cell-mediated cytotoxicity is discussed.

MeSH Terms
Antibodies, Monoclonal Cell Membrane/analysis,microbiology Cell Transformation, Viral Fluorescent Antibody Technique Herpesvirus 4, Human/genetics Humans Molecular Weight Transfection Viral Proteins/analysis Virion/analysis
Chemicals
Antibodies, Monoclonal Viral Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Mann K P
Staunton D
Thorley-Lawson D A
References (47)
47 references, click to expand
  1. Biological and biochemical observations on isolates of EB virus from the malignant epithelial cells of two nasopharyngeal carcinomas.
    Int J Cancer. 1979 Sep 15;24(3):294-302 PMID: 226484
  2. Epstein-Barr virus-specific RNA. III. Mapping of DNA encoding viral RNA in restringent infection.
    J Virol. 1979 Jan;29(1):261-74 PMID: 219221
  3. Identification of Epstein-Barr nuclear antigen polypeptide in mouse and monkey cells after gene transfer with a cloned 2.9-kilobase-pair subfragment of the genome.
    Proc Natl Acad Sci U S A. 1984 Jan;81(1):43-7 PMID: 6320171
  4. Reversible inhibition by phosphonoacetic acid of human B lymphocyte transformation by Epstein-Barr virus.
    Virology. 1978 May 15;86(2):423-31 PMID: 208257
  5. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  6. Fatal infectious mononucleosis in a family.
    N Engl J Med. 1974 Feb 14;290(7):363-7 PMID: 4358992
  7. Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8.
    J Virol. 1985 Feb;53(2):528-35 PMID: 2982035
  8. Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes.
    J Exp Med. 1977 Aug 1;146(2):495-508 PMID: 195004
  9. Epstein-Barr virus-specific cytotoxic T-cell clones restricted through a single HLA antigen.
    Nature. 1982 Jun 3;297(5865):413-5 PMID: 6176881
  10. Differential reactivity of human serums with early antigens induced by Epstein-Barr virus.
    Science. 1970 Jul 10;169(3941):188-90 PMID: 4316788
  11. Epstein-Barr virus-induced transformation of human leukocytes after cell fractionation.
    Int J Cancer. 1975 Jan 15;15(1):59-66 PMID: 47842
  12. Transformation and chromosome changes induced by Epstein-Barr virus in normal human leukocyte cultures.
    Proc Natl Acad Sci U S A. 1969 Jul;63(3):740-7 PMID: 5259761
  13. Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells.
    Science. 1967 Sep 1;157(3792):1064-5 PMID: 6036237
  14. Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells.
    Proc Natl Acad Sci U S A. 1966 Dec;56(6):1699-704 PMID: 16591407
  15. HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus.
    Proc Natl Acad Sci U S A. 1980 Jul;77(7):4247-50 PMID: 6254017
  16. Cellular oncogenes and multistep carcinogenesis.
    Science. 1983 Nov 18;222(4625):771-8 PMID: 6356358
  17. Induction of EBNA precedes the first cellular S-phase after EBV-infection of human lymphocytes.
    Int J Cancer. 1978 Feb 15;21(2):157-60 PMID: 203544
  18. Calcium, cyclic adenosine 3',5'-monophosphate, and the control of cell proliferation: a review.
    In Vitro. 1973 Jan-Feb;8(4):257-78 PMID: 4348032
  19. Indirect immunofluorescence tests with sera from African children and cultured Burkitt lymphoma cells.
    J Bacteriol. 1966 Jul;92(1):275-6 PMID: 5328753
  20. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study.
    Nature. 1978 Aug 24;274(5673):756-61 PMID: 210392
  21. Epstein-Barr virus RNA VII: size and direction of transcription of virus-specified cytoplasmic RNAs in a transformed cell line.
    Proc Natl Acad Sci U S A. 1981 Mar;78(3):1930-4 PMID: 6112750
  22. Heterogeneity of allogeneic restriction of human cytotoxic T cell clones specific for Epstein Barr virus.
    J Immunol. 1982 Mar;128(3):1241-5 PMID: 6173428
  23. Analysis of the transformation of human lymphocytes by Epstein-Barr virus. I. Sequential occurrence from the virus-determined nuclear antigen synthesis, to blastogenesis, to DNA synthesis.
    Intervirology. 1979;11(1):30-9 PMID: 218892
  24. Radiobiological inactivation of Epstein-Barr virus.
    J Virol. 1978 Jan;25(1):51-9 PMID: 202757
  25. Epstein-Barr virus membrane antigens: characterization, distribution, and strain differences.
    J Virol. 1981 Jul;39(1):172-84 PMID: 6268807
  26. Proteins of Epstein-Barr virus. I. Analysis of the polypeptides of purified enveloped Epstein-Barr virus.
    J Virol. 1976 Mar;17(3):935-49 PMID: 176452
  27. One of two Epstein-Barr virus nuclear antigens contains a glycine-alanine copolymer domain.
    Proc Natl Acad Sci U S A. 1983 Sep;80(18):5665-9 PMID: 6310587
  28. Lymphoblastoid transformation and kinetics of appearance of viral nuclear antigen (EBNA) in cord-blood lymphocytes infected by Epstein-Barr Virus (EBV).
    Int J Cancer. 1975 Mar 15;15(3):377-84 PMID: 49325
  29. A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection.
    Proc Natl Acad Sci U S A. 1984 Nov;81(22):7207-11 PMID: 6095274
  30. Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein.
    J Virol. 1984 Aug;51(2):411-9 PMID: 6086953
  31. BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus.
    J Immunol. 1985 May;134(5):3007-12 PMID: 2984280
  32. Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts.
    Cell. 1982 Sep;30(2):415-25 PMID: 6291768
  33. Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups.
    J Natl Cancer Inst. 1969 Nov;43(5):1147-57 PMID: 5353242
  34. Epstein-Barr virus (B95-8) DNA VII: molecular cloning and detailed mapping.
    Proc Natl Acad Sci U S A. 1980 May;77(5):2999-3003 PMID: 6248879
  35. DNA sequence and expression of the B95-8 Epstein-Barr virus genome.
    Nature. 1984 Jul 19-25;310(5974):207-11 PMID: 6087149
  36. Detection of antigens on nitrocellulose paper immunoblots with monoclonal antibodies.
    Anal Biochem. 1983 Aug;133(1):214-9 PMID: 6356979
  37. Calcium concentration defines two stages in transformation of lymphocytes by Epstein-Barr virus.
    Int J Cancer. 1984 May 15;33(5):587-90 PMID: 6327539
  38. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
    Anal Biochem. 1976 May 7;72:248-54 PMID: 942051
  39. Infection of human B lymphocytes with high multiplicities of Epstein-Barr virus: kinetics of EBNA expression, cellular DNA synthesis, and mitosis.
    Virology. 1981 Mar;109(2):336-43 PMID: 6259815
  40. Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line.
    J Virol. 1980 Nov;36(2):506-18 PMID: 6253674
  41. Preparation and properties of lymphocyte plasma membrane.
    Contemp Top Mol Immunol. 1974;3:27-56 PMID: 4611687
  42. Analysis of cellular immune response to EBV by using cloned T cell lines.
    J Immunol. 1983 May;130(5):2127-32 PMID: 6187840
  43. Identification of the filtrable leukocyte-transforming factor of QIMR-WIL cells as herpes-like virus.
    Int J Cancer. 1969 May 15;4(3):255-60 PMID: 5801413
  44. Production of functional human T-T hybridomas in selection medium lacking aminopterin and thymidine.
    Proc Natl Acad Sci U S A. 1982 Dec;79(23):7484-8 PMID: 6984190
  45. Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion.
    Eur J Immunol. 1976 Jul;6(7):511-9 PMID: 825377
  46. A new technique for the assay of infectivity of human adenovirus 5 DNA.
    Virology. 1973 Apr;52(2):456-67 PMID: 4705382
  47. Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation.
    Infect Immun. 1976 Feb;13(2):303-10 PMID: 177360
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1985-09-00
Pages
710-20
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC255052
Subset
IM
Grants
NIAID NIH HHS · AI00549 · United States
NIAID NIH HHS · AI15310 · United States
NCI NIH HHS · CA28737 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com